Key statistics
On Friday, Vivoryon Therapeutics NV (0R3M:LSE) closed at 1.38, 0.00% above its 52-week low of 1.38, set on Feb 13, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | -- |
|---|---|
| High | 1.38 |
| Low | 1.38 |
| Bid | -- |
| Offer | -- |
| Previous close | 1.41 |
| Average volume | 386.33 |
|---|---|
| Shares outstanding | 29.61m |
| Free float | 26.64m |
| P/E (TTM) | -- |
| Market cap | 41.46m EUR |
| EPS (TTM) | -0.4784 EUR |
Data delayed at least 20 minutes, as of Feb 13 2026 14:22 GMT.
More ▼
Announcements
- Vivoryon Therapeutics N.V. to Attend and Present in Upcoming Conferences
- Vivoryon Therapeutics N.V. Reports Q3 2025 Financial Results and Business Updates
- Vivoryon Therapeutics N.V. to Report Q3 2025 Financial Results and Operational Progress on December 4, 2025
- Vivoryon Therapeutics N.V. Presents Phase 2 Kidney Function and Biomarker Data at the American Society of Nephrology Kidney Week 2025
- Vivoryon Therapeutics N.V. to Present at Upcoming Conferences
- Vivoryon Therapeutics N.V. Successfully Completes Private Placement Raising EUR 5.1 Million
- Vivoryon Therapeutics N.V. Reports H1 2025 Financial Results and Business Updates
- Vivoryon Therapeutics N.V. to Report H1 2025 Financial Results and Operational Progress on September 4, 2025
- Vivoryon Therapeutics N.V. to Present at Upcoming Investor Conferences
- Vivoryon Therapeutics N.V. Reports Outcome of 2025 Annual General Meeting
More ▼
